The estimated Net Worth of Gary P. Pisano is at least $504 Tysiąc dollars as of 13 August 2021. Gary Pisano owns over 81,433 units of Axcella Health Inc stock worth over $372,963 and over the last 8 years he sold AXLA stock worth over $0. In addition, he makes $131,426 as Independent Director at Axcella Health Inc.
Gary has made over 2 trades of the Axcella Health Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 81,433 units of AXLA stock worth $22,801 on 13 August 2021.
The largest trade he's ever made was exercising 81,433 units of Axcella Health Inc stock on 13 August 2021 worth over $22,801. On average, Gary trades about 6,667 units every 125 days since 2016. As of 13 August 2021 he still owns at least 81,433 units of Axcella Health Inc stock.
You can see the complete history of Gary Pisano stock trades at the bottom of the page.
Dr. Gary P. Pisano serves as Independent Director of the Company. Dr. Pisano is the Harry E. Figgie, Jr. Professor of Business Administration and Senior Associate Dean for Faculty Development at the Harvard Business School. He has served on the Harvard faculty since 1988. Dr. Pisano's research and teaching focus on technology and operations strategy, the management of innovation and intellectual property, and competitive strategy. For more than two decades, he has consulted extensively on these issues with companies in the pharmaceutical, biotechnology, medical device, specialty chemical and healthcare industries. He has previously served as a director of Axovant Sciences Ltd. (Nasdaq: AXON) and Patheon NV (NYSE: PTHN).
As the Independent Director of Axcella Health Inc, the total compensation of Gary Pisano at Axcella Health Inc is $131,426. There are 8 executives at Axcella Health Inc getting paid more, with Shreeram Aradhye having the highest compensation of $3,911,720.
Gary Pisano is 58, he's been the Independent Director of Axcella Health Inc since 2011. There are 2 older and 14 younger executives at Axcella Health Inc. The oldest executive at Axcella Health Inc is Catherine Sohn, 67, who is the Independent Director.
Gary's mailing address filed with the SEC is C/O AXCELLA HEALTH INC., 840 MEMORIAL DRIVE, CAMBRIDGE, MA, 02139.
Over the last 6 years, insiders at Axcella Health Inc have traded over $32,393 worth of Axcella Health Inc stock and bought 29,966,648 units worth $79,278,835 . The most active insiders traders include Ventures Fund Iv General Pa..., Ventures Fund Iv General Pa... oraz Des Produits Nestle S.A.Nes.... On average, Axcella Health Inc executives and independent directors trade stock every 31 days with the average trade being worth of $3,073,698. The most recent stock trade was executed by Margaret Koziel on 1 March 2023, trading 679 units of AXLA stock currently worth $394.
axcella has pioneered a new therapeutic class – defined amino acid compositions (daacs™). our daac therapeutics leverage the essential signaling function of amino acids to restore health across a network of dysregulated pathways, and provide safer solutions for patients with complex disease. with our axcellerator™ platform, we are transforming traditional drug discovery and development by generating patient data in less than a year from indication selection. this platform has delivered a rich pipeline including clinical programs in liver, metabolic, cns and orphan diseases.
Axcella Health Inc executives and other stock owners filed with the SEC include: